![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
University of California, Davis |
---|---|
Information provided by: | University of California, Davis |
ClinicalTrials.gov Identifier: | NCT00367042 |
Mohs Micrographic Surgery is a well established method for treatment of cutaneous malignancies. Part of this technique requires marking skin surrounding the tumor. There are two ways of marking the tissue, lightly scoring it with a scalpel or marking it with a surgical marker.
This study is to determine if there is a noticeable difference in outcome between patients who have their tissue lightly scored with a scalpel or marked with a surgical marking pen.
Condition | Intervention | Phase |
---|---|---|
Skin Cancer |
Device: Scalpel for tissue scoring Device: Surgical marker for tissue marking |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind (Investigator), Active Control, Single Group Assignment |
Official Title: | Prospective Study To Determine Whether Tissue Scoring Results In Noticeable Marks Following Mohs Micrographic Surgery |
Estimated Enrollment: | 100 |
Study Start Date: | July 2005 |
Estimated Study Completion Date: | July 2008 |
Arms | Assigned Interventions |
---|---|
1: No Intervention |
Device: Scalpel for tissue scoring
During Mohs surgery we will compare the outcomes of scarring, to determine whether a mark (with a pen) or a score with a scalpel will receive the best scar.
Device: Surgical marker for tissue marking
You will be asked to participate, examined, discuss participation have procedure and come in for follow up for photos and check up.
|
Mohs Micrographic Surgery is a well established method utilizing microscopic margin controlled excision for treatment of cutaneous malignancies (See Appendix A). It has the highest cure rate of any of the methods used to treat common cutaneous malignancies and is a proven safe outpatient procedure. Part of the technique requires marking skin surrounding the tumor to correspond with tissue that has been removed and divided into pieces for processing and microscopic examination. Currently there are two established ways of marking the tissue; lightly scoring it with a scalpel or marking it with a surgical marker. Scoring tissue is faster, more accurate, and there is no risk of having the marking washed or rubbed away.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
UC Davis Medical Center Department of Dermatology | |
Sacramento, California, United States, 95816 |
Principal Investigator: | Daniel Eisen, M.D. | University of California, Davis |
Principal Investigator: | Thomas King, M.D. | University of California, Davis |
Responsible Party: | University of California Davis ( Daniel Eisen, MD ) |
Study ID Numbers: | 200513516-1 |
Study First Received: | August 19, 2006 |
Last Updated: | June 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00367042 |
Health Authority: | United States: Institutional Review Board |
Skin Diseases Skin Neoplasms |
Neoplasms Neoplasms by Site |